Jens M. Kelm

4.6k citations

40 papers · 3.3k indexed · 2 hit papers · h-index 24

Co-authors: Martin Fussenegger Lars K. Nielsen Irina Agarkova Nicholas Timmins Simon Messner Wolfgang Moritz Miriam Zimmermann Wilhelm Krek
Topics: 3D Printing in Biomedical Research (26 papers)Cancer Cells and Metastasis (14 papers)Viral Infectious Diseases and Gene Expression in Insects (6 papers)
Cited by: Biomedical Engineering Hepatology Oncology
Journals: PLoS ONE Nature Methods Cancer Research
Partner nations: Switzerland Austria Germany

In The Last Decade

Jens M. Kelm

40 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types

2003 734 citations Jens M. Kelm, Martin Fussenegger et al. profile →
3D cell culture systems modeling tumor growth determinants in cancer target discovery

2014 382 citations Claudio R. Thoma, Miriam Zimmermann et al. Advanced Drug Delivery Reviews profile →

Peers

Countries citing papers authored by Jens M. Kelm

Since Specialization

Citations

This map shows the geographic impact of Jens M. Kelm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens M. Kelm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens M. Kelm more than expected).

Fields of papers citing papers by Jens M. Kelm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens M. Kelm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens M. Kelm. The network helps show where Jens M. Kelm may publish in the future.

Co-authorship network of co-authors of Jens M. Kelm

This figure shows the co-authorship network connecting the top 25 collaborators of Jens M. Kelm. A scholar is included among the top collaborators of Jens M. Kelm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens M. Kelm. Jens M. Kelm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Data standards in drug discovery: A long way to go 2024 ·Drug Discovery Today ·Jens M. Kelm,Marc Ferrer,Martin-Immanuel Bittner,(unknown)	1
2	A 3D Heterotypic Multicellular Tumor Spheroid Assay Platform to Discriminate Drug Effects on Stroma versus Cancer Cells 2019 ·SLAS DISCOVERY ·(unknown),Madhu Lal‐Nag,(unknown),Christoph Thiel,(unknown),(unknown),Patrick Guye,Jens M. Kelm,Marc Ferrer	23
3	Translational in vitro research: integrating 3D drug discovery and development processes into the drug development pipeline 2018 ·Drug Discovery Today ·Jens M. Kelm,Madhu Lal‐Nag,G. Sitta Sittampalam,Marc Ferrer	28
4	Development of a 3D angiogenesis model to study tumour – endothelial cell interactions and the effects of anti-angiogenic drugs 2017 ·Scientific Reports ·Arno Amann,Marit Zwierzina,(unknown),Gabriele Gamerith,Elisabeth Pechriggl,Julia Huber,Edith Lorenz,Jens M. Kelm,Wolfgang Hilbe,H. Zwierzina,Johann Kern	53
5	Transcriptomic, Proteomic, and Functional Long-Term Characterization of Multicellular Three-Dimensional Human Liver Microtissues 2017 ·PubMed ·Simon Messner,Lisa Fredriksson,Volker M. Lauschke,(unknown),Claudia Escher,(unknown),Jens M. Kelm,Magnus Ingelman‐Sundberg,Wolfgang Moritz	55
6	A novel three-dimensional heterotypic spheroid model for the assessment of the activity of cancer immunotherapy agents 2016 ·Cancer Immunology Immunotherapy ·Sylvia Herter,Laura Morra,Ramona Schlenker,(unknown),Linda Fahrni,Inja Waldhauer,Steffi Lehmann,Timo Reisländer,Irina Agarkova,Jens M. Kelm,Christian Klein,Pablo Umaña,Marina Bacac	108
7	Infiltration of lymphocyte subpopulations into cancer microtissues as a tool for the exploration of immunomodulatory agents and biomarkers 2016 ·Immunobiology ·(unknown),Marit Zwierzina,Julia Huber,Mario Bitsche,Edith Lorenz,Gabriele Gamerith,József Dudás,Jens M. Kelm,H. Zwierzina,Arno Amann	6
8	Evaluation of assays for drug efficacy in a three-dimensional model of the lung 2016 ·Journal of Cancer Research and Clinical Oncology ·Julia Huber,Arno Amann,(unknown),Edith Lorenz,Jens M. Kelm,Petra Obexer,H. Zwierzina,Gabriele Gamerith	33
9	A 3D-microtissue-based phenotypic screening of radiation resistant tumor cells with synchronized chemotherapeutic treatment 2015 ·BMC Cancer ·Nataša Anastasov,Ines Höfig,Vanja Radulović,Simon Ströbel,Michael Salomon,Jan Lichtenberg,Ina Rothenaigner,Kamyar Hadian,Jens M. Kelm,Christian Thirion,Michael J. Atkinson	41
10	Stem Cell-Derived Systems in Toxicology Assessment 2015 ·Stem Cells and Development ·Laura Suter‐Dick,Paula M. Alves,Bas J. Blaauboer,(unknown),Catarina Brito,Sandra Coecke,Burkhard Flick,Paul Fowler,Jürgen Hescheler,Magnus Ingelman‐Sundberg,Paul Jennings,Jens M. Kelm,Irene Manou,Pratibha Mistry,Angelo Moretto,Adrian Roth,Donald B. Stedman,Bob van de Water,Mario Beilmann	43
11	96-Well Format-Based Microfluidic Platform for Parallel Interconnection of Multiple Multicellular Spheroids 2014 ·SLAS TECHNOLOGY ·Jinyoung Kim,David A. Fluri,Jens M. Kelm,Andreas Hierlemann,Olivier Frey	57
12	Hepatic toxicology following single and multiple exposure of engineered nanomaterials utilising a novel primary human 3D liver microtissue model 2014 ·Particle and Fibre Toxicology ·Ali Kermanizadeh,(unknown),Martin Roursgaard,Simon Messner,Patrina Gunness,Jens M. Kelm,Peter Möller,Vicki Stone,Steffen Loft	70
13	3D cell culture systems modeling tumor growth determinants in cancer target discoverybreakdown → 2014 ·Advanced Drug Delivery Reviews ·Claudio R. Thoma,Miriam Zimmermann,Irina Agarkova,Jens M. Kelm,Wilhelm Krek	382
14	Development of an Innovative 3D Cell Culture System to Study Tumour - Stroma Interactions in Non-Small Cell Lung Cancer Cells 2014 ·PLoS ONE ·Arno Amann,Marit Zwierzina,Gabriele Gamerith,Mario Bitsche,Julia Huber,Georg F. Vogel,Michael Blumer,(unknown),Elisabeth Pechriggl,Jens M. Kelm,Wolfgang Hilbe,H. Zwierzina	130
15	An in vitro osteosarcoma 3D microtissue model for drug development 2014 ·Journal of Biotechnology ·Markus Rimann,Sandra Laternser,Ana Gvozdenovic,Roman Muff,Bruno Fuchs,Jens M. Kelm,Ursula Graf‐Hausner	57
16	Multi-cell type human liver microtissues for hepatotoxicity testing 2012 ·Archives of Toxicology ·Simon Messner,Irina Agarkova,Wolfgang Moritz,Jens M. Kelm	247
17	Towards automated production and drug sensitivity testing using scaffold‐free spherical tumor microtissues 2011 ·Biotechnology Journal ·(unknown),(unknown),(unknown),(unknown),Wolfgang Moritz,Jan Lichtenberg,Jens M. Kelm	100
18	Entzündliche Erkrankungen der Wirbelsäule und des Myelons 2011 ·Der Radiologe ·F. Ahlhelm,Johanna Lieb,S. Ulmer,Till Sprenger,Christoph Stippich,Jens M. Kelm	2
19	Microscale tissue engineering using gravity-enforced cell assembly 2004 ·Trends in biotechnology ·Jens M. Kelm,Martin Fussenegger	238
20	SAMY , a novel mammalian reporter gene derived from Bacillus stearothermophilus α-amylase 2002 ·Gene ·Stefan Schlatter,Markus Rimann,Jens M. Kelm,Martin Fussenegger	125

About Jens M. Kelm

Jens M. Kelm is a scholar working on Oncology, Biomedical Engineering and Hepatology, having authored 40 papers that have together received 3.3k indexed citations. Recurring topics across this work include 3D Printing in Biomedical Research (26 papers), Cancer Cells and Metastasis (14 papers) and Viral Infectious Diseases and Gene Expression in Insects (6 papers). The work is most often cited by research in Biomedical Engineering (2.0k citations), Hepatology (343 citations) and Oncology (985 citations). Jens M. Kelm has collaborated with scholars based in Switzerland, Austria and Germany. Frequent co-authors include Martin Fussenegger, Lars K. Nielsen, Irina Agarkova, Nicholas Timmins, Simon Messner, Wolfgang Moritz, Miriam Zimmermann, Wilhelm Krek, Claudio R. Thoma and Stefan Schlatter. Their work appears in journals such as PLoS ONE, Nature Methods and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact